Apex Healthcare Bhd
KLSE:AHEALTH
Gross Margin
Apex Healthcare Bhd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
MY |
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
1.4B MYR |
23%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
685.8B USD |
81%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
362.5B USD |
69%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
85%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
196.2B CHF |
73%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
205.6B USD |
81%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
176.4B CHF |
75%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
155.9B GBP |
82%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD |
68%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
128.2B USD |
74%
|
Apex Healthcare Bhd
Glance View
Apex Healthcare Bhd.is an investment holding company, which engages in the manufacture and trade of pharmaceutical and consumer healthcare products. The company is headquartered in Malacca, Melaka. The company went IPO on 2000-06-26. The firm operates through three segments: Manufacturing, Distribution, and Corporate. The Manufacturing segment is engaged in manufacturing and marketing of pharmaceutical products. The Distribution segment is engaged in wholesale, marketing, and distribution of pharmaceutical, consumer healthcare products and medical devices. The Corporate segment comprising investments, properties and others. The company develops manufacture and market XEPA branded off-patent generic pharmaceuticals and medical devices. The company also conducts contract manufacturing for pharmaceutical companies. The company provides specialist market access services for pharmaceutical companies through the provision of regulatory, redressing, sales, marketing and logistics services via a network of eight distribution facilities in Singapore and Malaysia. Its subsidiaries include Xepa-Soul Pattinson (Malaysia) Sdn. Bhd., Apex Pharmacy Marketing Sdn. Bhd. and ABio Marketing Sdn. Bhd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Apex Healthcare Bhd's most recent financial statements, the company has Gross Margin of 23.5%.